Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI). Advani, Ranjana H , Chen, Haiyan , Habermann, Thomas M ... - - Br. J. Haematol. - 2010 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - C9793
Attributes and Outcomes of Older Adults in Surgical Oncology Trials: Results from ACOSOG Z901101 (Alliance) Al-Refaie, Waddah B. , Decker, Paul A. , Pisters, Peter W.T. ... - SSO - Ann. Surg. Oncol. - 2015 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Older Adult - Z901101
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Al-Refaie, Waddah B , Decker, Paul A , Ballman, Karla V ... - - Ann. Surg. Oncol. - 2019 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Older Adult - Z901101
Exercise and Dietary Change after Diagnosis and Cancer-related Symptoms in Long-term Survivors of Breast Cancer: CALGB 79804 Alfano, Catherine M. , Day, Jeannette M. , Katz, Mira L. ... - - Psychooncology - 2009 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-70804
Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data Apoe, Ogheneruona , Jung, Sin-Ho , Liu, Heshan , Seisler, Drew K ... - - Am J Hematol Oncol - 2016 Manuscript - Primary Endpoint - Preliminary Analysis - Prevention - CALGB-70806
Effects of a lymphedema prevention intervention on range of motion among women receiving axillary node dissection for breast cancer treatment (Alliance) CALGB 70305 Armer, Jane M , Liu, Heshan , Oliveri, Jill , Seisler, Drew , tbd ... - ASCO CSS - J. Clin. Oncol. - 2018 Abstract - Secondary Endpoint - Primary Analysis - Symptom Inter - CALGB-70305
Healthy Eating Index Scores are Associated with Inflammatory Markers in Breast Cancer Survivors Arnold, Kristen , Andridge, Rebecca , Logan, Amanda , Yee, Lisa ... - EB - FASEB J - 2015 Abstract - Secondary Endpoint - Primary Analysis - Symptom Inter - NCT01478477
Using the Skindex-16 and CTCAE to assess rash symptoms: Results of a pooled-analysis (N0993). Atherton, P. , Burger, K. , Loprinzi, C. , Miller, R. , Jatoi, A. ... - - J. Clin. Oncol. - 2010 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - NCCTG-N0993
Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993) Atherton, Pamela J. , Burger, Kelli N. , Loprinzi, Charles L. ... - - Support Care Cancer - 2012 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N0993
Assessment of Patient-Reported Measures of Bowel Function Before and After Pelvic Radiotherapy: An Ancillary Study of the North Central Cancer Treatment Group Study N00CA Atherton, Pamela J. , Halyard, Michele Y. , Sloan, Jeff A. ... - - Support Care Cancer - 2013 Manuscript - Secondary Endpoint - Primary Analysis - Symptom Inter - N00CA
The Complementary Nature of Patient-Reported Outcomes (PROs) and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591) Atherton, Pamela J. , Watkins-Bruner, Deborah W. , Gotay, Carolyn ... - - J Pain Symptom Manage - 2015 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - N0591
Patient Reported Outcomes Questionnaire Compliance in Cancer Cooperative Group Trials (Alliance N0992) Atherton, Pamela J , Burger, Kelli N , Pederson, Levi D ... - - Clin Trials - 2016 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - N0992
Measurement of Affective and Activity Pain Interference Using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903 Atkinson, Thomas M. , Halabi, Susan , Bennett, Antonia V. ... - - Pain Med - 2012 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-70903
Comparison Between Clinician- and Patient-Reporting of Baseline (BL) and Post-BL Symptomatic Toxicities in Cancer Cooperative Group Clinical Trials (NCCTG N0591 [Alliance]) Atkinson, Thomas M. , Satele, Daniel V. , Sloan, Jeff A. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - N0591
Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101 Barginear, Myra , Dueck, Amylou C. , Allred, Jacob B. ... - - Oncologist - 2019 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - A151411 , CALGB-40101 , CALGB-70301
The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5) Barton, D. L. , Atherton, P. J. , Bauer, B. A. , Moore, D. F. Jr ... - - J Support Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N01C5
Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9 Barton, D. L. , Lavasseur, B. I. , Sloan, J. A. , Stawis, A. N. ... - - J. Clin. Oncol. - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N05C9
A phase III trial evaluating three doses of citalopram for hot flashes: NCCTG trial N05C9 Barton, D. L. , Lavasseur, B. , Sloan, J. A. , Stella, P. J. ... - - J. Clin. Oncol. - 2008 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N05C9
Phase III evaluation of American ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N07C2 Barton, D. L. , Liu, H. , Dakhil, S. R. , Linquist, B. M. ... - - J. Clin. Oncol. - 2012 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N07C2
Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: A randomized, double-blind trial, N07C2 Barton, D. L. , Liu, H. , Dakhil, S. R. , Linquist, B. , Sloan, J. A. ... - - J. Natl. Cancer Inst. - 2013 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N07C2
Long-acting methylphenidate for cancer-related fatigue: NCCTG trial N05C7 Barton, D. L. , Moraska, A. R. , Sood, A. , Sloan, J. A. , Suh, J. J. ... - - J. Clin. Oncol. - 2010 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N05C7
Can gabapentin improve control of delayed nausea and vomiting (N/V)? A phase III placebo controlled trial, N08C3 (Alliance) Barton, D. L. , Sloan, J. A. , Novotny, P. J. , Fuloria, J. ... - - Support Care Cancer - 2013 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N08C3
Does gabapentin prevent delayed chemotherapy-induced nausea and vomiting (N/V)? Results of a randomized placebo controlled trial, NCCTG N08C3 (Alliance) Barton, D. L. , Sloan, J. A. , Novotny, P. J. , Fuloria, J. ... - - J. Clin. Oncol. - 2013 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N08C3
A pilot, multi-dose, placebo-controlled evaluation of american ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N03CA Barton, D. L. , Soori, G. S. , Bauer, B. , Sloan, J. , Johnson, P. A. ... - - J. Clin. Oncol. - 2007 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N03CA
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA Barton, D. L. , Wos, E. J. , Qin, R. , Mattar, B. I. , Green, N. B. ... - - Support Care Cancer - 2011 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N06CA
A randomized controlled trial evaluating a topical treatment for chemotherapy-induced neuropathy: NCCTG trial N06CA Barton, D. L. , Wos, E. , Qin, R. , Mattar, B. , Green, N. , Lanier, K. ... - - J. Clin. Oncol. - 2009 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N06CA
Adiponectin: A novel biomarker for cancer- related fatigue?; NCCTG study N07C2 (Alliance) Barton, D. , Liu, H. , Tan, A. , Sloan, J. ... - MASCC / ISOO - Support Care Cancer - 2013 Abstract - Secondary Endpoint - Primary Analysis - Symptom Inter - N07C2
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 Barton, Debra L. , Burger, Kelli , Novotny, Paul J. , Fitch, Tom R. ... - - Support Care Cancer - 2013 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N00C9
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance) Barton, Debra L. , Shuster, Lynne T. , Dockter, Travis ... - - Support Care Cancer - 2018 Manuscript - Secondary Endpoint - Primary Analysis - Symptom Inter - N10C1
Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance) Barton, Debra L. , Sloan, Jeff A. , Shuster, Lynne T. , Gill, Paula ... - - Support Care Cancer - 2018 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N10C1
Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance) Barton, Debra L. , Sloan, Jeff A. , Shuster, Lynne T , Gill, Paula ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N10C1
Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA Barton, Debra L. , Soori, Gamini S. , Bauer, Brent A. ... - - Support Care Cancer - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N03CA
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance) Barton, Debra L. , Thanarajasingam, Gita , Sloan, Jeff A. ... - - Cancer - 2014 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N08C3
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. Barton, Debra L , Wender, Donald B , Sloan, Jeff A , Dalton, Robert J ... - - J. Natl. Cancer Inst. - 2007 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - NCCTG-N02C3
Addressing the Complexities of Sexual Health in Female Cancer Survivors: NCCTG N10C1 (Alliance) Barton, Debra , Dockter, Travis , Atherton, Pamela , Lester, Joanne ... - CANS - - 2014 Abstract - Secondary Endpoint - Primary Analysis - Symptom Inter - N10C1
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - JAMA Oncol - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-30607 , CALGB-30610 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-70501 , CALGB-70604 , CALGB-80405 , CALGB-90401
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048 Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - J. Clin. Oncol - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N1048
Evaluation of mode equivalence of the MSKCC Bowel Function Instrument, LASA Quality of Life, and Subjective Significance Questionnaire items administered by Web, interactive voice response system (IVRS), and paper Bennett, Antonia V. , Keenoy, Kathleen , Shouery, Marwan ... - - Qual Life Res - 2016 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - NCT01458509
Sequencing symptom control: Results from the Alliance N08C1 and N08CA genetics of chemotherapy neuropathy trials Beutler, A. S. , Kulkarni, A. , Kanwar, R. , Qin, R. ... - AACR - AACR 2013 Annual Meeting - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C1 , N08CA
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy Beutler, Andreas S. , Kulkarni, Amit A. , Kanwar, Rahul ... - - Ann. Neurol. - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C1 , N08CA
Perioperative Patient Reported Outcomes Predict Serious Postoperative Complications: A Secondary Analysis of the COST Trial Bingener, Juliane , Sloan, Jeff A. , Novotny, Paul J. ... - - J. Gastrointest. Surg. - 2015 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - NCCTG-93-46-53
Cognitive Function and Discontinuation of Adjuvant Hormonal Therapy in Older Breast Cancer Survivors: CALGB 369901 (Alliance) Bluethmann, Shirley M. , Alfano, Catherine M. , Clapp, Jonathan D. ... - - Breast Cancer Res. Treat. - 2017 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-369901
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance) Boora, Ganesh K. , Kanwar, Rahul , Kulkarni, Amit A. , Abyzov, Alexej ... - - Cancer Med - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C1
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance) Boora, Ganesh K. , Kulkarni, Amit A. , Kanwar, Rahul ... - - J. Neurol. Sci. - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08CA
Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1 Brown, L. C. , Atherton, P. J. , Neben-Wittich, M. A. , Wender, D. B. ... - - Support Care Cancer - 2013 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - N09C1
Teaching Health-Care Providers to Query Patients With Cancer About Sexual and Gender Minority (SGM) Status and Sexual Health Cathcart-Rake, Elizabeth J. , Breitkopf, Carmen Radecki ... - - Am J Hosp Palliat Care - 2019 Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Disparities - Pilot
How (and why) to ask the older cancer patient about sexual health and sexual minority status. Cathcart-Rake, Elizabeth , O'Connor, Jennifer M , Jacobson, Alison ... - - J Geriatr Oncol - 2019 Manuscript - No-Endpoint Endpoint - Other Analysis - Disparities - Pilot
Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology Cerhan, Jane H , Anderson, S Keith , Butts, Alissa M , Porter, Alyx B ... - - Neurooncol Pract - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N0577 , A221101 , N0874 , N107C
Patient satisfaction with participation in phase II/III NCCTG clinical trials: Was it worth it? (N0392) Chauhan, C. , Atherton, P. J. , Satele, D. , Dueck, A. C. ... - ASCO - J. Clin. Oncol. - 2012 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - NCCTG-N0392
Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB) Cheville, Andrea L. , Sloan, Jeff A. , Northfelt, Donald W. ... - - Support Care Cancer - 2009 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N01CB
Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803) Cohen, Harvey Jay , Lan, Lan , Archer, Laura ... - - J Geriatr Oncol - 2012 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - C70103 , CALGB-70803
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Croghan, Ivana T , Hurt, Richard D , Dakhil, Shaker R ... - - Mayo Clin. Proc. - 2007 Manuscript - Primary Endpoint - Primary Analysis - Prevention - NCCTG-N99C4
The Feasibility of Radiotherapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial. Cuttino, Laurie , McCall, Linda , Kubicky, C , Ballman, Karla ... - ASTRO - International Journal of Radiation Oncology • Biology • Physics - 2019 Abstract - Primary Endpoint - Primary Analysis - Prevention - Z11102
Is there a role for older-patient-specific trials? a pooled analysis of 2277 older patients in adjuvant breast cancer trials (Alliance A151715) Dao, Dyda , Zelma, Tyler , Jatoi, Aminah , Freedman, Rachel ... - ASCO - J Clin Oncol - 2018 Abstract - Primary Endpoint - Primary Analysis - Older Adult - A151715 , C8541 , CALGB-40101 , CALGB-49907 , CALGB-9344 , CALGB-9741 , N89-30-52 , N9831
Older‐Patient‐Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715) Dao, Dyda , Zemla, Tyler , Jatoi, Aminah , Freedman, Rachel A. ... - - Oncologist - 2019 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - A151715 , CALGB-49907 , CALGB-40401
Perceived Risk for Cancer Progression and Psychological Status in Chronic Lymphocytic Leukemia Patients: CALGB 70603 (Alliance) Deshields, Teresa , Dueck, Amylou C. , Rogers, Kerry ... - - Leuk. Lymphoma - 2019 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-70603 , CALGB-10501 , CALGB-70603
Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group Diehl, Kathleen M. , Green, Erin M. , Weinberg, Armin ... - - Ann. Surg. Oncol. - 2011 Manuscript - Primary Endpoint - Primary Analysis - Disparities - Comprehensive
Participation in cancer pharmacogenomic studies in 8,456 patients registered to Cancer and Leukemia Group B (Alliance) clinical trials Dressler, L. G. , Deal, A. M. , Watson, D. , Hollis, D. , Owzar, K. ... - - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401
Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance) Dressler, Lynn G. , Deal, Allison M. , Owzar, Kouros ... - - J. Natl. Cancer Inst - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80101 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401
Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Dueck, A. C. , Mendoza, T. R. , Mitchell, S. A. , Reeve, B. B. ... - - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - Comprehensive
Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance) Dueck, A. C. , Singh, J. , Atherton, P. , Liu, H. , Novotny, P. ... - - Osteoporos Int - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N02C1 , N03CC
Calibrating clinically significant effects in survival and response endpoints in cancer clinical trials. Dueck, A. , Sargent, D. , Novotny, P. , Decker, P. , Nelson, H. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N0591
Validity and Reliability of the U.S. National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Dueck, Amylou C. , Mendoza, Tito R. , Mitchell, Sandra A. ... - - JAMA Oncol - 2015 Manuscript - No-Endpoint Endpoint - Primary Analysis - Health Outcome - Comprehensive
Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance) Durá-Ferrandis, Estrella , Mandelblatt, Jeanne S. , Clapp, Jonathan ... - - Psychooncology - 2017 Manuscript - Secondary Endpoint - Long-Term-Followup Analysis - Older Adult - CALGB-369901
Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901 Faul, Leigh Anne , Luta, Gheorghe , Sheppard, Vanessa ... - - J Cancer Surviv - 2014 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-369901
Do Older Patients with Metastatic Non-Small Cell Lung Cancer Also Benefit from First-Line Platinum-Based Doublet Chemotherapy? Feliciano, Josephine L. , Le-Rademacher, Jennifer G. , Gajra, Ajeet ... - - J Geriatr Oncol - 2018 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - CALGB-30203 , A151622 , CALGB-30801 , CALGB-9730
Analysis of longitudinal quality of life data in high-risk operable patients with lung cancer: Results from ACOSOG Z4032 (Alliance) a multicenter randomized trial Fernando, Hiran C , Landreneau, Rodney J , Mandrekar, Sumithra J ... - - J. Thorac. Cardiovasc. Surg. - 2015 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - ACOSOG-Z4032
Factors contributing to cancer screening in African Americans Ferrans, C. E. , Ryan, C. , Archer, L. E. , Freels, S. , Lan, L. ... - - J. Clin. Oncol. - 2008 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-119901
Comparative “Nocebo Effects” in Older Patients Enrolled in Cancer Therapeutic Trials: Observations From a 446-Patient Cohort Foster, Jared C. , Le-Rademacher, Jennifer G. ... - - Cancer - 2017 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - ACOSOG-Z9001 , A151602 , NCCTG-97-24-51
Comparative nocebo findings in older patients enrolled in cancer therapeutic trials: observations from a 446-patient cohort (Alliance A151602) Foster, Jared C. , Le-Rademacher, Jennifer G. ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Primary Endpoint - Primary Analysis - Older Adult - A151602 , ACOSOG-Z9001 , NCCTG-97-24-51
Changes in Cognitive Function in Older Women With Breast Cancer Treated with Standard Chemotherapy and Capecitabine within CALGB 49907 Freedman, R. , Pitcher, B. , Keating, N. , Barry, W. , Ballman, K. ... - - Cancer Res. - 2012 Abstract - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-49907
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602) Freedman, Rachel A. , Dockter, Travis J. , Lafky, Jacqueline M. ... - - Oncologist - 2018 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - A171602
Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527 Freedman, Rachel A. , Foster, Jared C. , Seisler, Drew K. ... - - J. Clin. Oncol - 2017 Manuscript - Primary Endpoint - Comprehensive Analysis - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831
Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907 Freedman, Rachel A. , Pitcher, Brandelyn , Keating, Nancy L. ... - - Breast Cancer Res. Treat. - 2013 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-49907 , CALGB-361002
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511) Freedman, Rachel A. , Seisler, D. K. , Foster, J. C. , Sloan, J. A. ... - - Breast Cancer Res. Treat. - 2017 Manuscript - Primary Endpoint - Comprehensive Analysis - Older Adult - CALGB-40101 , A151511 , CALGB-49907 , CALGB-9344 , CALGB-9741
Accrual of Older Breast Cancer Patients to Alliance Systemic Therapy Protocols over Time: Alliance A151527 (Multiple) Freedman, Rachel A , Seisler, Drew K. , Foster, Jared C. ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Primary Endpoint - Comprehensive Analysis - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831
The Preference to Receive Chemotherapy and Cancer-related Outcomes in Older Adults with Breast Cancer CALGB 49907 (Alliance) Gajra, Ajeet , McCall, Linda , Muss, Hyman B. , Cohen, Harvey J ... - - J Geriatr Oncol - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - CALGB-49907
Time-to-Treatment-Failure and Related Outcomes among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711) Gajra, Ajeet , Zemla, Tyler J. , Jatoi, Aminah ... - - J Thorac Oncol - 2018 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - A151711 , CALGB-30203 , CALGB-30801 , CALGB-9730
Predictors of accrual success for cooperative group trials: The Cancer and Leukemia Group B (Alliance) experience Gordon, David , Liu, Qianying , Kleinman, Benjamin ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - Comprehensive
Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7 Grothey, Axel , Nikcevich, Daniel A. , Sloan, Jeff A. ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N04C7
Determination of Utility Scores for Control of Chemotherapy-Induced Nausea or Vomiting—CALGB 309801 Grunberg, S. M. , Weeks, J. , Magnan, W. F. , Herndon, J. 2nd ... - - J Support Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - Disparities - CALGB-309801
Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance) Guercio, Brendan J. , Sato, Kaori , Niedzwiecki, Donna , Ye, Xing ... - - J. Clin. Oncol - 2015 Manuscript - Secondary Endpoint - Primary Analysis - Prevention - C89803
Persistent Fatigue in Hematopoietic Stem Cell Transplantation Survivors Hacker, Eileen Danaher , Fink, Anne M. , Peters, Tara , Park, Chang ... - - Cancer Nurs - 2017 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - Pilot
Persistent Fatigue in Stem Cell Transplant Survivors: A Biobehavioral Perspective Hacker, Eileen Danaher , Fink, Anne , Peters, Tara , Park, Chang ... - ONS - Biol. Blood Marrow Transplant. - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - Pilot
Real-Time Fatigue and Free-Living Physical Activity in Hematopoietic Stem Cell Transplantation Cancer Survivors and Healthy Controls: A Preliminary Examination of the Temporal, Dynamic Relationship Hacker, Eileen Danaher , Kim, Inah , Park, Chang ... - - Cancer Nurs - 2017 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - Pilot
Assessing the clinical significance of real-time Quality of Life (QOL) data in cancer patients treated with radiation therapy Halyard, M. Y. , Tan, A. D. , Callister, M. D. , Ashman, J. B. ... - ASCO - J. Clin. Oncol. - 2010 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - NCCTG-89-20-52
Effect of socioeconomic status as measured by education level on survival in breast cancer clinical trials Herndon, J. E. , Kornblith, A. B. , Holland, J. C. ... - - Psycho-Oncology - 2013 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Disparities - Comprehensive
Patient Education Level As a Predictor of Survival In Lung Cancer Clinical Trials Herndon, James E. , Kornblith, Alice B. , Holland, Jimmie C. ... - - J Clin Oncol - 2008 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-70601
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases Himelstein, Andrew L. , Foster, Jared C. , Khatcheressian, James L. ... - - JAMA - 2017 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - CALGB-70604 , CALGB-150804
CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer Himelstein, Andrew L. , Qin, Rui , Novotny, Paul J. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - CALGB-70604
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC Hines, Stephanie L. , Mincey, Betty , Dentchev, Todor ... - - Breast Cancer Res. Treat. - 2009 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N03CC
Lymphedema, Musculoskeletal Events and Arm Function in Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer (Alliance A171302) Hopkins, Judith O. , Allred, Jake , Hurria, Arti , Jatoi, Aminah ... - - Breast Cancer Res. Treat. - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - CALGB-49907 , A171302
Functional Decline and Resilience among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer Hurria, Arti , Soto-Perez-de-Celis, Enrique , Allred, Jacob B. ... - - J Am Geriatr Soc - 2019 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-361007 , CALGB-49907
Reproducibility of Random Periareolar Fine Needle Aspiration in a Multi-Institutional Cancer and Leukemia Group B (CALGB) Cross-Sectional Study Ibarra-Drendall, Catherine , Wilke, Lee G. , Zalles, Carola ... - - Cancer Epidemiol. Biomarkers Prev. - 2009 Manuscript - Primary Endpoint - Primary Analysis - Prevention - Comprehensive
Can a Gastric Cancer Risk Survey Identify High-Risk Patients for Endoscopic Screening? A Pilot Study In, Haejin , Langdon-Embry, Marisa , Gordon, Lauren ... - - J. Surg. Res. - 2018 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - Pilot
A Pilot Case Control Study: Could a Gastric Cancer Risk Screening Tool Help Identify High Risk Patients for Endoscopic Screening in the US? In, Haejin , Langdon-Embry, Marisa , Gordon, Lauren ... - SSO - Ann. Surg. Oncol. - 2018 Abstract - Primary Endpoint - Primary Analysis - Disparities - Pilot
A Pilot Case Control Study: Could a Gastric Cancer Risk Screening Tool Help Identify High Risk Patients for Endoscopic Screening in the US? In, Haejin , Langdon-Embry, Marisa , Gordon, Lauren ... - ASCO GI - J Clin Oncol - 2018 Abstract - Primary Endpoint - Primary Analysis - Disparities - Pilot
Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance) Jansson-Knodell, Claire L. , Foster, Nathan R. , Sargent, Daniel J. ... - - J Gastrointest Oncol - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Prevention - N0147
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. Jatoi, A , Steen, P D , Atherton, P J , Moore, D F , Rowland, K M ... - - Ann. Oncol. - 2017 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N02C4
Prophylactic Tetracycline Does Not Diminish the Severity of Epidermal Growth Factor Receptor (EGFR) Inhibitor Induced Rash: Results from the North Central Cancer Treatment Group (Supplementary N03CB)1 Jatoi, Aminah , Dakhil, Shaker R. , Sloan, Jeff A. , Kugler, John W. ... - - Support Care Cancer - 2011 Manuscript - Secondary Endpoint - Primary Analysis - Symptom Inter - N03CB
Social Support and Its Implications in Older, Early-Stage Breast Cancer Patients in CALGB 49907 (Alliance A171301) Jatoi, Aminah , Muss, Hyman , Allred, Jake B. , Cohen, Harvey J. ... - - Psychooncology - 2016 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-49907 , A171301
A Pilot Study of Long-Acting Octreotide for Symptomatic Malignant Ascites (N04C2) Jatoi, Aminah , Nieva, Jorge J. , Qin, Rui , Loprinzi, Charles L. ... - - Oncology - 2012 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N04C2
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Jatoi, Aminah , Ritter, Howard L , Dueck, Amylou , Nguyen, Phuong L ... - - Lung Cancer - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N01C9
Tetracycline to Prevent Epidermal Growth Factor Receptor Inhibitor-Induced Skin Rashes: Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N03CB)1 Jatoi, Aminah , Rowland, Kendrith , Sloan, Jeff A. , Gross, Howard M. ... - - Cancer - 2008 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N03CB
Does Sunscreen Prevent Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash? Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N05C4) Jatoi, Aminah , Thrower, Abby , Sloan, Jeff A. , Flynn, Patrick J. ... - - Oncologist - 2010 Manuscript - Primary Endpoint - Primary Analysis - Prevention - N05C4
Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803 / ALLIANCE Jeon, Justin , Sato, Kaori , Niedzwiecki, Donna , Ye, Xing ... - - Clin Colorectal Cancer - 2013 Manuscript - Secondary Endpoint - Primary Analysis - Prevention - CALGB-89803
The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women Ji, YongLi , Rounds, Tiffany , Crocker, Abigail , Sussman, Betsy ... - - Cancer Prev Res (Phila) - 2016 Manuscript - Primary Endpoint - Primary Analysis - Prevention - NCT00914017
Regional Differences In Breast Cancer Biomarkers In American Indian And Alaska Native Women Kaur, Judith S , Vierkant, Robert A. , Hobday, Timothy ... - - Cancer Epidemiol. Biomarkers Prev. - 2014 Manuscript - Primary Endpoint - Primary Analysis - Disparities - NCCTG-97-95-51
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8 Kearns, Ann E. , Northfelt, Donald W. , Dueck, Amylou C. ... - - Support Care Cancer - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N01C8
Using ePrognosis to Estimate 2-year All-Cause Mortality in Older Women with Breast Cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503) Kimmick, Gretchen G , Major, Brittny , Clapp, Jonathan , Sloan, Jeff ... - - Breast Cancer Res. Treat. - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - A151503 , CALGB-369901 , CALGB-49907
Determining All-Cause Survival Estimates using ePrognosis in Older Women with Breast Cancer in CALGB 49907 and 369901 (Alliance A151503) Kimmick, Gretchen , Pitcher, Brandelyn , Mandelblatt, Jeanne ... - SABCS - Cancer Res. - 2016 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - A151503 , CALGB-369901 , CALGB-49907
Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer (BC) Klepin, H. D. , Pitcher, B. , Ballman, K. V. , Kimmick, G. G. ... - - J. Clin. Oncol. - 2012 Abstract - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-70103 , CALGB-49907
Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance) Klepin, Heidi D. , Pitcher, Brandelyn N. , Ballman, Karla V. ... - - J Oncol Pract - 2014 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-49907 , CALGB-361004
Feasibility of geriatric assessment for older adults with acute myeloid leukemia (AML) receiving intensive chemotherapy on a cooperative group trial: CALGB 361006 (Alliance). Klepin, Heidi D. , Ritchie, Ellen K. , Sanford, Ben L. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary Endpoint - Primary Analysis - Older Adult - CALGB-361006
Quality of Life of Older Patients With Early-Stage Breast Cancer Receiving Adjuvant Chemotherapy: A Companion Study to Cancer and Leukemia Group B 49907 Kornblith, Alice B. , Lan, Lan , Archer, Laura , Partridge, Ann ... - - J Clin Oncol - 2011 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - C70103 , CALGB-49907
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial Kottschade, Lisa A. , Sloan, Jeff A. , Mazurczak, Miroslaw A. ... - - Support Care Cancer - 2011 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N05C3
Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance) Kottschade, Lisa , Novotny, Paul , Lyss, Alan , Mazurczak, Miroslaw ... - - Support Care Cancer - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C3
Increasing Adherence to Adjuvant Hormone Therapy among Breast Cancer Patients: A Smart Phone App-Based Pilot Study Krok-Schoen, Jessica L. , Naughton, Michelle J. , Young, Gregory S. ... - ASCO - J Clin Oncol - 2018 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - Pilot
RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial N08C1 Kulkarni, Amit A. , Boora, Ganesh , Kanwar, Rahul , Ruddy, Kathryn J. ... - - Acta Oncol - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08C1 , N08CA
Differences in clinical trial patient attributes and outcomes according to trial enrollment setting: Analyses from 10 CALGB lung cancer trials Lamont, E. B. , Archer, L. E. , Lan, L. , Vokes, E. E. , Mcneil, B. J. ... - - J. Clin. Oncol. - 2008 Abstract - Primary Endpoint - Primary Analysis - Disparities - CALGB-70602
Survival of clinical trial subjects vs elderly Medicare patients with extensive stage small cell lung cancer following treatment with cisplatin and etoposide Lamont, E. B. , He, Y. , Lan, L. ... - - J Geriatr Oncol - 2011 Abstract - Primary Endpoint - Primary Analysis - Disparities - CALGB-70802
Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens Lamont, E. B. ... - - Med Care - 2014 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - CALGB-9344 , CALGB-9730 , CALGB-9235 , CALGB-9732 , CALGB-80203 , CALGB-89803
Measuring Clinically Significant Chemotherapy-Related Toxicities Using Medicare Claims From Cancer and Leukemia Group B (CALGB) Trial Participants Lamont, Elizabeth B. , Herndon, James E. , Weeks, Jane C. ... - - Med Care - 2008 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-70101
Differences in Clinical Trial Patient Attributes and Outcomes According to Enrollment Setting Lamont, Elizabeth B. , Landrum, Mary Beth , Keating, Nancy L. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Disparities - CALGB-70602
Generalizability of Trial Results to Elderly Medicare Patients with Advanced Solid Tumors (Alliance 70802) Lamont, Elizabeth B. , Schilsky, Richard L. , He, Yulei , Muss, Hyman ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-70802
Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802) Lamont, Elizabeth B. , Yu, Menggang , He, Yulei , Saltz, Leonard ... - - J Geriatr Oncol - 2014 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-70802
Psychometric Testing of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization (CI-PeriNomS) and Alliance for Clinical Trials in Oncology (Alliance) A151408 Study Data Lavoie Smith, Ellen M. , Banerjee, Tanima , Yang, James J. ... - - Cancer Nurs - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - A151408
Comparison of results from three different density assessment methods on mammographic density (MD) in a screening patients receiving vitamin D (Vit D): Results of CALGB 70806 (Alliance) Le-Petross, Huong T. , Seisler, Drew K. , Kontos, Despina ... - RSNA - - 2018 Abstract - Secondary Endpoint - Primary Analysis - Prevention - CALGB-70806
Association Between Patient Perception of Oncology Clinical Trial Participation and Survival: NCCTG N0392 (Alliance) Le-Rademacher, Jennifer , Dueck Amylou , Chauhan, Cynthia ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-N0392
Association Between Patient Perception of Oncology Clinical Trial Participation and Survival: NCCTG N0392 (Alliance) Le-Rademacher, Jennifer , Dueck, Amylou , Chauhan, Cynthia ... - MASCC / ISOO - - 2016 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-N0392
Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials Le-Rademacher, Jennifer , Kanwar, Rahul , Seisler, Drew ... - - Support Care Cancer - 2017 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Symptom Inter - N08CA , N08CB
NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study Leal, Alexis D. , Qin, Rui , Atherton, Pamela J. , Haluska, Paul ... - - Cancer - 2014 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N08CA
Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance]) Leenstra, James L. , Miller, Robert C. , Qin, Rui ... - - J. Clin. Oncol - 2014 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N09C6
A randomized, double-blind, placebo-controlled trial of testosterone (T) for aromatase inhibitor-induced arthralgias (AIA) in postmenopausal women: Alliance study A221102 Leon-Ferre, Roberto A. , Novotny, Paul , Terstriep, Shelby ... - SABCS - Cancer Res - 2019 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - A221102
Identifying Risk Factors For Toxicity In Patients With Hormone-Receptor Positive Advanced Breast Cancer Treated With Bevacizumab Plus Letrozole: A CALGB 40503 (Alliance) Correlative Study Li, Daneng , Dickler, Maura N. , McCall, Linda M. , Hahn, Olwen M ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-40503
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: A CALGB 40503 (Alliance) correlative study. Li, Daneng , McCall, Linda M. , Hahn, Olwen M , Hudis, Clifford A. ... - - Breast Cancer Res. Treat. - 2018 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-40503
Effect of renal function (RF) on outcomes in the adjuvant treatment of older women with breast cancer (>65 years): CALGB/CTSU 49907 (CC) ancillary data study Lichtman, S. M. , Cirrincione, C. , Hurria, A. , Jatoi, A. ... - - J. Clin. Oncol. - 2013 Abstract - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-49907 , A171201
Paclitaxel in older women with breast cancer. Combined analysis of CALGB 9342 and 9840 with a focus on age Lichtman, S. M. , Hurria, A. , Cirrincione, C. T. , Seidman, A. D. ... - - Cancer Res. - 2009 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Older Adult - CALGB-360701 , CALGB-9342 , CALGB-9840
Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907 Lichtman, Stuart M. , Cirrincione, Constance T. , Hurria, Arti ... - - J. Clin. Oncol - 2016 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - A171201 , CALGB-49907
Body mass index (BMI), tumor subtype, and relapse-free survival (RFS) in CALGB 9741 (Alliance) Ligibel, J. A. , Cirricione, C. , Liu, M. , Citron, M. , Ingle, J. ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Disparities - C9741
Impact of a Telephone-Based Physical Activity Intervention upon Exercise Behaviors and Fitness in Cancer Survivors Enrolled in a Cooperative Group Setting Ligibel, Jennifer A. , Meyerhardt, Jeffrey , Pierce, John P. ... - - Breast Cancer Res. Treat. - 2012 Manuscript - Primary Endpoint - Primary Analysis - Prevention - NCT00548236
Comparing and validating simple measures of patient-reported peripheral neuropathy (PRPN) for NCCTG Clinical Trials: A pooled analysis of 2,440 patients (pts) Liu, H. , Tan, A. D. , Grothey, A. , Schaefer, P. L. , Buckner, J. C. ... - - J. Clin. Oncol. - 2008 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Symptom Inter - Comprehensive
Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients Liu, Heshan , Tan, Angelina D. , Qin, Rui , Sargent, Daniel J. ... - - SOJ Anesthesiol Pain Manag - 2015 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - N0897
A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: NCCTG study N04CA Loprinzi, C. L. , Balcueva, E. P. , Liu, H. , Kottschade, L. A. ... - - J. Clin. Oncol. - 2010 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N04CA
A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA Loprinzi, C. L. , Balcueva, E. P. , Liu, H. , Sloan, J. A. ... - - J Support Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N04CA
Gabapentin for hot flashes in men: NCCTG trial N00CB Loprinzi, C. L. , Khoyratty, B. S. , Dueck, A. , Barton, D. L. ... - - J. Clin. Oncol. - 2007 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N00CB
Phase III randomized, placebo (PL)-controlled, double-blind study of intravenous calcium/magnesium (CaMg) to prevent oxaliplatin-induced sensory neurotoxicity (sNT), N08CB: An Alliance for Clinical Trials in Oncology study Loprinzi, C. L. , Qin, R. , Dakhil, S. R. , Fehrenbacher, L. ... - - J. Clin. Oncol. - 2013 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N08CB
Pregabalin for hot flashes in women: NCCTG trial N07C1 Loprinzi, C. L. , Qin, R. , Stella, P. J. , Rowland, K. M., Jr ... - - J. Clin. Oncol. - 2009 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N07C1
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1 Loprinzi, C. L. , Reeves, B. N. , Dakhil, S. R. , Sloan, J. A. ... - - J. Clin. Oncol. - 2011 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - N08C1
Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1 Loprinzi, Charles L. , Qin, Rui , Baclueva, Ernie P. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N07C1
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance) Loprinzi, Charles L. , Qin, Rui , Dakhil, Shaker R. ... - - J. Clin. Oncol - 2014 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N08CB
Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. Loprinzi, Charles L , Kugler, John W , Barton, Debra L ... - - J. Clin. Oncol. - 2007 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N03C5
Prevention of aromatase Inhibitor (AI)-induced joint symptoms with omega-3 fatty acid supplementation: A randomized placebo-controlled pilot study Lustberg, M.B. , Orchard, T. , Pan, X. , Reinbolt, R. , Logan, A. ... - SABCS - Cancer Res - 2015 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01478477
Randomized Placebo-Controlled Pilot Trial of Omega 3 Fatty Acids for Prevention of Aromatase Inhibitor-Induced Musculoskeletal Pain Lustberg, Maryam B , Orchard, Tonya S. , Reinbolt, Raquel ... - - Breast Cancer Res. Treat. - 2018 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01478477
Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance) Major-Elechi, Brittny T. , Novotny, Paul J. , Singh, Jasvinder A. ... - - Int J Stat Med Res - 2018 Manuscript - No-Endpoint Endpoint - Other Analysis - Health Outcome - NCCTG-89-20-52
Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901 Mandelblatt, J. S. , Faul, L. A. , Luta, G. , Makgoeng, S. B. ... - - J. Clin. Oncol. - 2012 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-369901
Patient preference as a determinant of breast cancer adjuvant chemotherapy use in older women: CALGB 369901 Mandelblatt, J. , Sheppard, V. , Hurria, A. , Kimmick, G. G. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-369901
Frailty and Long-term Mortality Of Older Breast Cancer Patients: CALGB 369901 (Alliance) Mandelblatt, Jeanne S. , Cai, Ling , Luta, George , Kimmick, Gretchen ... - - Breast Cancer Res. Treat. - 2017 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-369901
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance) Mandelblatt, Jeanne S. , Clapp, Jonathan D. , Luta, Gheorghe ... - ICCTF - Cancer - 2016 Abstract - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-369901
Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance) Mandelblatt, Jeanne S. , Clapp, Jonathan D. , Luta, Gheorghe ... - - Cancer - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - CALGB-369901
A planned, prospective comparison of short-term quality of life outcomes among older breast cancer patients treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB 49907 and 369901 Mandelblatt, Jeanne S. , Makgoeng, Solomon B. , Luta, Gheorghe ... - - J Geriatr Oncol - 2013 Manuscript - Secondary Endpoint - Comprehensive Analysis - Older Adult - CALGB-49907 , CALGB-369901
Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions With Physicians Mandelblatt, Jeanne S. , Sheppard, Vanessa B. , Hurria, Arti ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - CALGB-369901
Phase III, Double-Blind Study of Depot Octreotide Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy: Results of North Central Cancer Treatment Group N00CA Martenson, James A. , Halyard, Michele Y. , Sloan, Jeff A. ... - - J Clin Oncol - 2008 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N00CA
How Much Missing Data is Too Much? Monte Carlo Simulations to Develop SISAQOL Guidelines for Missing Data Handling. Mazza, Gina L. , Coens, Corneel , Pe, Madeline , Dorme, Lien ... - ISOQOL - Qual Life Res - 2018 Abstract - No-Endpoint Endpoint - Other Analysis - Health Outcome -
Dietary Glycemic Load and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings From CALGB 89803 Meyerhardt, J. A. , Sato, K. , Niedzwiecki, D. , Ye, C. , Saltz, L. B. ... - - J Natl Cancer Inst - 2012 Manuscript - Secondary Endpoint - Primary Analysis - Prevention - CALGB-89803 , CALGB-159806
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. Meyerhardt, Jeffrey A , Heseltine, Denise , Niedzwiecki, Donna ... - - J. Clin. Oncol. - 2006 Manuscript - Secondary Endpoint - Primary Analysis - Prevention - CALGB-89803
Primary and Secondary Endpoint Analysis of N08C9 (Alliance)- A Phase III Randomized Trial of Sulfasalazine versus Placebo in the Prevention of Acute Radiation Enteritis Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASTRO - INT J RADIAT BIOL - 2014 Abstract - Secondary Endpoint - Primary Analysis - Symptom Inter - N08C9
Primary and Secondary Endpoint Analysis of N08C9 (Alliance)- A Phase III Randomized Trial of Sulfasalazine versus Placebo in the Prevention of Acute Radiation Enteritis Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASCO GI - J. Clin. Oncol. - 2015 Abstract - Secondary Endpoint - Primary Analysis - Symptom Inter - N08C9
N08C9 (Alliance) - A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2013 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N08C9
N09C6 (Alliance) -A phase III, randomized double-blind study of N09C6 rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy Miller, R. , Leenstra, J. , Qun, R. , Martenson, J. , Dornfeld, J. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2013 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N09C6
A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus “Magic Mouthwash” versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy (Alliance A221304) Miller, Robert C. , Le-Rademacher, Jennifer , Sio, Terence ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - A221304
N09C6 (Alliance) - A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Placebo in the Treatment of Acute Oral Mucositis Pain: Secondary analysis of the continuation phase Miller, Robert C. , Leenstra, James L. , Qin, Rui ... - - European Journal of Cancer - 2013 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N09C6
N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine vs Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy Miller, Robert C. , Petereit, Daniel G. , Sloan, Jeff A. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N08C9
Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase 3 Double-Blind, Randomized Trial from the North Central Cancer Treatment Group N06C4 Miller, Robert C. , Schwartz, David J. , Sloan, Jeff A. ... - - Int J Radiat Oncol Biol Phys - 2011 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N06C4
Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB Moraska, A. R. , Atherton, P. J. , Szydlo, D. W. , Barton, D. L. ... - - J Support Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N00CB
Gabapentin for the management of hot flashes in prostate cancer survivors: A longitudinal continuation study—NCCTG trial N00CB Moraska, A. R. , Atherton, P. J. , Szydlo, D. W. , Barton, D. L. ... - - J. Clin. Oncol. - 2010 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N00CB
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial Moraska, A. R. , Sood, A. , Dakhil, S. R. , Sloan, J. A. , Barton, D. ... - - J. Clin. Oncol. - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N05C7
The Impact of Actual Body Weight-Based Chemotherapy Dosing and Body Size on Adverse Events and Outcome in Older Patients with Breast Cancer: Results from Cancer and Leukemia Group B (CALGB) Trial 49907 (Alliance A151436) Morrison, Vicki A. , McCall, Linda , Muss, Hyman B. , Jatoi, Aminah ... - - J Geriatr Oncol - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - A151436 , CALGB-49907
Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim Moukharskaya, J. , Abrams, D.M. , Ashikaga, T. , Khan, F. ... - - Support Care Cancer - 2016 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01311336
Randomized phase II pilot study of loratadine for the prevention of bone pain caused by pegfilgrastim. Moukharskaya, Julia , Abrams, Deborah Michelle , Khan, Farrah B. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01311336
Who Participates in an Adult Cooperative Group Trial for Adolescent and Young Adults (AYAs)? Baseline Demographic and Psychosocial Characteristics of AYAs Enrolled On Intergroup Trial C10403 for Acute Lymphoblastic Leukemia (ALL) Muffly, L. S. , Stock, W. , Breitenbach, K. , Mulkey, F. , Luger, S. ... - ASH - Blood - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Disparities - CALGB-10403 , C10403
Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907 Muss, H. B. , Berry, D. A. , Cirrincione, C. T. , Theodoulou, M. ... - - J. Clin. Oncol. - 2008 Abstract - Primary Endpoint - Primary Analysis - Older Adult - CALGB-49907
Quality of life (QOL) and toxicity among patients in CALGB 80405 Naughton, M. J. , Schrag, D. , Venook, A. P. , Niedzwiecki, D. ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - C80405
Health-related quality of life outcomes for the LEAP Study - Alliance 70305: a lymphedema prevention intervention trial for newly-diagnosed breast cancer patients Naughton, MJ , Seisler, DK , Sloan, JA , Liu, H , Le-Rademacher, J ... - ISOQOL - Qual Life Res - 2018 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-70305
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - - N. Engl. J. Med. - 2016 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - A221301
Olanzapine For The Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In Patients Receiving Highly Emetogenic Chemotherapy (HEC): Alliance A221301 A Randomized, Double-Blind, Placebo-Controlled Trial Navari, Rudolph M. , Qin, Rui , Ruddy, Kathryn J. , Liu, Heshan ... - ASCO Pal - J. Clin. Oncol. - 2015 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - A221301
Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4) Neben-Wittich, Michelle A. , Atherton, Pamela J. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2011 Manuscript - Secondary Endpoint - Primary Analysis - Symptom Inter - N06C4
Cancer and Aging: Reflections for Elders (CARE): A pilot randomized controlled trial of a psychotherapy intervention for older adults with cancer Nelson, Christian J. , Saracino, Rebecca M. , Roth, Andrew J. ... - - Psychooncology - 2019 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - Pilot
Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer Ng, Kimmie , Meyerhardt, Jeffrey A. , Chan, Andrew T. , Sato, Kaori ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary-not-in-original Endpoint - Long-Term-Followup Analysis - Prevention - C89803
Electronic Patient-Reported Outcomes and Toxicities During Radiotherapy for Head and Neck Cancer Niska, Joshua R. , Halyard, Michele Y. , Tan, Angelina D. ... - - Qual Life Res - 2017 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - NCCTG-892052
Feasibility of a text-based smoking cessation intervention in rural older adults Noonan, D , Silva, S , Njuru, J , Bishop, T , Fish, L J , Simmons, L A ... - - Health Educ Res - 2018 Manuscript - Primary Endpoint - Primary Analysis - Prevention - NCT02510716
Addressing Tobacco Use Disparities in Rural Older Adults through a Mobile Phone Intervention: Project Wise Noonan, Devon , Silva, Susan , Fish, Laura , Simmons, Leigh Ann ... - RCC - - 2017 Abstract - Primary Endpoint - Primary Analysis - Prevention - NCT02510716
Addressing Tobacco Use Disparities in Rural Older Adults through a Mobile Phone Intervention: Project Wise Noonan, Devon , Silva, Susan , Njuru, J. , Bishop, T. , Fish, Laura J. ... - SRNT - - 2017 Abstract - Primary Endpoint - Primary Analysis - Prevention - NCT02510716
Arm swelling and psychological well-being among long-term breast cancer survivors Oliveri, J. M. , Day, J. , Alfano, C. M. , Herndon, J. E. 2nd ... - APHA - American Public Health Association Annual Meeting - 2007 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-79804
Arm/Hand Swelling and Perceived Functioning among Breast Cancer Survivors 12 Years Post-diagnosis: CALGB 79804 Oliveri, Jill M. , Day, Jeannette M. , Alfano, Catherine M. ... - - J Cancer Surviv - 2008 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-79804
Relationship of dietary and red blood cell (RBC) polyunsaturated fatty acids (PUFAs) to inflammatory markers in breast cancer survivors taking Aromatase Inhibitors (AI) Orchard, TS , Pan, X , Lester. J , Logan, A , Shapiro, CL , Jackson, RD ... - SABCS - Cancer Res. - 2015 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01478477
Testing a Mixture of Fats and Oils for Use as a Placebo in Clinical Trials. Orchard, Tonya S. , Belury, Martha A. , Cole, Rachel ... - AOCS - - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - NCT01478477
Diet Quality, Inflammation and Quality of Life in Breast Cancer Survivors; a Cross-Sectional Analysis of Pilot Study Data Orchard, Tonya , Andridge, Rebecca R. , Yee, Lisa D. ... - - J Acad Nutr Diet - 2018 Manuscript - Secondary Endpoint - Primary Analysis - Symptom Inter - NCT01478477
Randomized Clinical Trial of Imiquimod: An Adjunct to Treating Cervical Dysplasia Pachman, Deirdre R. , Barton, Debra L. , Clayton, Amy H. ... - - Am J Obstet Gynecol - 2012 Manuscript - Primary Endpoint - Primary Analysis - Prevention - NCCTG-989251
Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance) Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary Endpoint - Primary Analysis - Symptom Inter - N08CB
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance) Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. , Smith, Ellen M.L. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary Endpoint - Primary Analysis - Symptom Inter - N08CB
Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505) Pachman, Deirdre R. , Qin, Rui , Seisler, Drew ... - - Support Care Cancer - 2016 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - A151505 , N08C1 , N08CB
Lessons learned from implementing the first Alliance NCORP Research Base Cancer Care Delivery Research (CCDR) trial A191402CD Pacyna, Joel E. , Sloan, Jeff , Kim, Simon , Sedlacek, Hillary ... - ASCO QCS - J Clin Oncol - 2018 Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Disparities - A191402CD
NCCTG N10C2 (Alliance) – A Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - - Menopause - 2015 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N10C2
NCCTG N10C2 (Alliance): A double-blind, placebo-controlled study of magnesium supplements to reduce menopausal hot flashes Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N10C2
Dietary modification in patients with prostate cancer on active surveillance: a randomized, multicentre feasibility study. Parsons, J Kellogg , Newman, Vicky A , Mohler, James L ... - - BJU Int. - 2008 Manuscript - Primary Endpoint - Primary Analysis - Prevention - Comprehensive
The Men's Eating and Living (MEAL) study: a Cancer and Leukemia Group B pilot trial of dietary intervention for the treatment of prostate cancer. Parsons, J Kellogg , Newman, Vicky , Mohler, James L , Pierce, John P ... - - Urology - 2008 Manuscript - Primary Endpoint - Primary Analysis - Prevention - Comprehensive
A Randomized Trial of Diet in Men with Early Stage Prostate Cancer on Active Surveillance: Rationale and Design of the Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance]) Parsons, J. Kellogg , Pierce, John P. , Mohler, James ... - - Contemp Clin Trials - 2014 Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Prevention - CALGB-70807
The Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance]): Recruitment Feasibility and Baseline Demographics of a Randomized Trial of Diet in Men on Active Surveillance for Prostate Cancer Parsons, J. Kellogg , Pierce, John P. , Mohler, James ... - - BJU Int. - 2018 Manuscript - Secondary-not-in-original Endpoint - Preliminary Analysis - Prevention - CALGB-70807
A Randomized Pilot Trial of Dietary Modification for the Chemoprevention of Non-invasive Bladder Cancer: The Dietary Intervention in Bladder Cancer Study (DIBS) Parsons, J. Kellogg , Pierce, John P. , Natarajan, Loki ... - - Cancer Prev Res (Phila) - 2013 Manuscript - Primary Endpoint - Primary Analysis - Prevention - Pilot
The Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance]): A Randomized Clinical Trial of a Diet Intervention in Men on Active Surveillance for Prostate Cancer Parsons, J. Kellogg , Zarieh, David , Pierce, John P. , Mohler, James ... - AUA - J Urol - 2018 Abstract - Primary Endpoint - Primary Analysis - Prevention - CALGB-70807
Applying a Conceptual Model for Examining Health-Related Quality of Life in Long-Term Breast Cancer Survivors: CALGB Study 79804 Paskett, Electra D. , Herndon, James E. , Day, Jeannette M. ... - - Psychooncology - 2008 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - C8541 , CALGB-79804
Health-Related Quality of Life in Long-Term Breast Cancer Survivors: Differences by Adjuvant Chemotherapy Dose in CALGB Study 8541 Paskett, Electra , Herndon, James , Donohue, Kathleen ... - - Cancer - 2009 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - C8541 , CALGB-79804
Prevention of Lymphedema in Women with Breast Cancer: Results of CALGB 70305 (Alliance) Paskett, Electra , Oliveri, Jill , Le-Rademacher, Jennifer ... - ASCO CSS - J. Clin. Oncol. - 2017 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - CALGB-70305
Improving standards of patient reported outcomes analysis: developing a consensus taxonomy of key research objectives – a SISAQOL initiative Pe , M. , L., Dorme , C., Coens , E., Basch , Melanie, Calvert ... - ISOQOL - Qual Life Res - 2018 Abstract - No-Endpoint Endpoint - Other Analysis - Health Outcome -
Tobacco Assessment in Completed Lung Cancer Treatment Trials Peters, Erica N. , Warren, Graham W. , Sloan, Jeff A. ... - - Cancer - 2016 Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Prevention - Comprehensive
Differences in psychosocial factors among diverse women enrolled in a phase III cooperative group metastatic breast cancer trial (CALGB 40502/Alliance) Polite, B. N. , Allred, J. B. , Rugo, H. S. , Cipriano, T. ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Disparities - C40502
The evaluation of flaxseed for hot flashes: Results of a randomized, controlled trial, NCCTG study N08C7 Pruthi, S. , Qin, R. , Terstriep, S. A. , Liu, H. , Loprinzi, C. L. ... - - J. Clin. Oncol. - 2011 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N08C7
A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes1:NCCTG N08C7 Pruthi, Sandhya , Qin, Rui , Terstreip, Shelby A. , Liu, Heshan ... - - Menopause - 2012 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N08C7
Quality of Life Analysis of N0877 (Alliance): Phase II Trial of Either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM) Qin, Rui , Tan, Angelina D. , Sloan, Jeff A. , Johnson, Derek Richard ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - N0877
Natural history of paclitaxel-associated acute pain syndrome (P-APS): NCCTG trial N08C1 Reeves, B. , Dakhil, S. R. , Sloan, J. A. , Kamal, A. , Wolf, S. L. ... - - J. Clin. Oncol. - 2010 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - N08C1
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1. Reeves, Brandi N , Dakhil, Shaker R , Sloan, Jeff A , Wolf, Sherry L ... - - Cancer - 2012 Manuscript - Secondary Endpoint - Long-Term-Followup Analysis - Symptom Inter - N08C1
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). Romanus, Dorothy , Kindler, Hedy L , Archer, Laura , Basch, Ethan ... - - J Pain Symptom Manage - 2012 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-80303
Adherence, persistence and toxicity with oral CMF in older women with early stage breast cancer in CALGB 49907 (adherence companion study 60104) Ruddy, K. , Archer, L. E. , Cohen, H. J. , Winer, E. P. , Hudis, C. A. ... - - Cancer Res. - 2010 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - C60104
A Comparison of the Natural History of Oxaliplatin- and Paclitaxel-Induced Neuropathy (NCCTG N08C1, N08CB/Alliance) Ruddy, Kathryn Jean , Pachman, Dierdre , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - A151505 , N08C1 , N08CB
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601 SMITH, E.M.L. , PANG, H. , YE, C. , CIRRINCIONE, C. , FLEISHMAN, S. ... - - Eur J Cancer Care (Engl) - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-170601
A patterns-of-care study of post-progression treatment (Rx) among patients (pts) with advanced pancreas cancer (APC) after gemcitabine therapy on Cancer and Leukemia Group B (CALGB) study 80303 Schrag, D. , Archer, L. E. , Wang, X. , Romanus, D. , Mulcahy, M. ... - - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-80303
Clinical trial participants' strategies for coping with prescription drug costs: A companion study to CALGB 80405 Schrag, D. , Naughton, M. J. , Kesselheim, A. , Archer, L. E. ... - ASCO - J. Clin. Oncol. - 2009 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - C80405
Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405. Schrag, Deborah , Dueck, Amylou C. , Naughton, Michelle Joy ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-80405 , CALGB-70502
The Complicated ‘Yes’: Decision -Making Processes and Receptivity to Lung Cancer Screening Among Head and Neck Cancer Survivors Seaman, Aaron T. , Dukes, Kimberly , Hoffman, Richard M. ... - - Patient Educ Couns - 2018 Manuscript - Primary Endpoint - Primary Analysis - Prevention - Pilot
Effect of zoledronic acid (ZA) on bone mineral density (BMD) in premenopausal women who develop ovarian failure (OF) due to adjuvant chemotherapy (AdC): First results from CALGB trial 79809 Shapiro, C. L. , Halabi, S. , Gibson, G. , Friedlander, R. J. ... - - J. Clin. Oncol. - 2008 Abstract - Primary Endpoint - Preliminary Analysis - Symptom Inter - CALGB-79809
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809 Shapiro, C. L. , Halabi, S. , Hars, V. , Archer, L. , Weckstein, D. ... - - Eur. J. Cancer - 2011 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - CALGB-79809
Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance) Shapiro, Charles L. , Moriarty, James P. , Dusetzina, Stacie ... - - J. Clin. Oncol - 2017 Manuscript - Secondary Endpoint - Primary Analysis - Symptom Inter - CALGB-70604
Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901 Sheppard, Vanessa B. , Faul, Leigh Anne , Luta, George ... - - J. Clin. Oncol - 2014 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - CALGB-369901
Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans Shofer, Scott , Beyea, Matthew , Li, Sufeng , Bastian, Lori A ... - - BMJ Open Respir Res - 2014 Manuscript - Primary Endpoint - Primary Analysis - Prevention - NCT01038492
Executive function in rural older adult smokers: influence of depression and nicotine dependence (NCT02510716) Silva, Nikolas J. , Conley, Cherie , Shawn McClintock ... - SBM - Annals of Behavioral Medicine - 2018 Abstract - Primary Endpoint - Primary Analysis - Disparities - NCT02510716
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales. Singh, Jasvinder A , Locke, Dona E , Satele, Daniel ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - 954651 , NCCTG-95-20-53 , NCCTG-95-24-52 , 959204 , NCCTG-964251 , 979202 , NCCTG-98-24-52 , NCCTG-98-72-51 , NCCTG-98-72-52 , NCCTG-959257 , NCCTG-989251 , NCCTG-969256 , NCCTG-971151 , NCCTG-979251 , NCCTG-979253
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales Singh, Jasvinder A , Satele, Daniel , Pattabasavaiah, Suneetha ... - - Health Qual Life Outcomes - 2014 Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-95-20-53 , 954651 , 959204 , NCCTG-95-24-52 , NCCTG-964251 , 979202 , NCCTG-97-24-51 , NCCTG-98-24-52 , NCCTG-98-72-51 , NCCTG-959257 , NCCTG-98-72-52 , NCCTG-989251 , NCCTG-969256 , NCCTG-971151 , NCCTG-979251 , NCCTG-979253
Repeated Measures Analyses of Dermatitis Symptom Evolution in Breast Cancer Patients Receiving Radiotherapy in a Phase 3 Randomized Trial of Mometasone Furoate vs Placebo (N06C4 [Alliance]) Sio, Terence T. , Atherton, Pamela J. , Birckhead, Brandon J ... - - Support Care Cancer - 2016 Manuscript - Secondary Endpoint - Primary Analysis - Symptom Inter - N06C4
Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial Sio, Terence T. , Atherton, Pamela J. , Pederson, Levi D. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2019 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - MC1221
Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain Sio, Terence T. , Le-Rademacher, Jennifer G. , Leenstra, James L. ... - - JAMA - 2019 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - A221304
Expansion of the Wilson & Cleary Theoretical Model to Incorporate Genetic Influences on Quality of Life Sloan J ... - ISOQOL - - 2010 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-N9741
A patient-level pooled analysis of the prognostic significance of baseline fatigue for overall survival (OS) among 3,915 patients participating in 43 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials. Sloan, J. A. , Liu, H. , Sargent, D. J. , Satele, D. , Schaefer, P. L. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - Comprehensive
Was it worth it (WIWI)? patient satisfaction with clinical trial participation: Results from North Central Cancer Treatment Group (NCCTG) Phase III Trial N0147 Sloan, J. A. , Mahoney, M. R. , Sargent, D. J. , Hubbard, J. M. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - NCCTG-N0147
Relationship between genetic markers and quality of life (QOL) in stage III colon cancer (CC) patients (pts) prior to adjuvant treatment (N0147). Sloan, J. A. , Shi, Q. , Lee, A. , Diasio, R. B. , Pavey, E. S. ... - ASCO - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - NCCTG-N0147
Lessons from Large Scale Collection of Patient Reported Outcomes: Implications for Big Data Aggregation and Analytics Sloan, Jeff A. , Halyard, Michele , El Naqa, Issam ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Manuscript - No-Endpoint Endpoint - Other Analysis - Health Outcome - N9741 , NCCTG-89-20-52
Prognostic significance of baseline fatigue for overall survival: A patient-level meta-analysis of 43 oncology clinical trials with 3915 patients Sloan, Jeff A. , Liu, H. , Satele, D.V. , Puttabasavaiah, S. ... - - Trends Cancer Res - 2017 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - N0591
Combining survival and toxicity effect sizes from clinical trials into an interpretable, quality-adjusted survival effect size estimate of treatment efficacy. Sloan, Jeff A. , Major, Brittny , Novotny, Paul J. , Grothey, Axel ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - NCCTG-89-20-52
Calibration of Quality-Adjusted Life Years for Oncology Clinical Trials Sloan, Jeff A. , Sargent, Daniel J. , Novotny, Paul J. ... - - J Pain Symptom Manage - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - NCCTG-89-20-52
The reliability, validity, and sensitivity of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-chemotherapy-induced Peripheral Neuropathy (QLQ-CIPN-20). Smith, E. M. L. , Yang , J. , Banerjee, T. , Loprinizi, C. ... - MNRS - - 2016 Abstract - Secondary Endpoint - Primary Analysis - Symptom Inter - N06CA , CI-PeriNomS , N08C1 , N08CA , N08CB
Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data Smith, Ellen M. Lavoie , Zanville, Noah , Kanzawa-Lee, Grace ... - - Support Care Cancer - 2019 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - A151408 , N06CA , N08C1 , N08CA , N08CB
Cultural and ethnic variables improve a survey’s ability to identify individuals at high risk for gastric cancer Solsky, Ian , Parides, Michael , Schechter, Clyde , Rapkin, Bruce ... - SSO - - 2019 Abstract - Primary Endpoint - Primary Analysis - Disparities - Pilot
Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare Population Soulos, Pamela R. , Yu, James B. , Roberts, Kenneth B. ... - - J. Clin. Oncol - 2012 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Older Adult - CALGB-9343
Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states Sprangers, Mirjam A. G. , Bartels, Meike , Veenhoven, Ruut ... - - Qual Life Res - 2010 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - N9741
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes Sprangers, Mirjam A. G. , Sloan, Jeff A. , Barsevick, Andrea ... - - Qual Life Res - 2010 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - N9741
A Survey of Survivors Stark, Nancy - - Appl Clin Trials - 2007 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - Comprehensive
Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)☆ Tallarico, Michael , Foster, Jared C. , Seisler, Drew ... - - J Geriatr Oncol - 2018 Manuscript - Secondary Endpoint - Primary Analysis - Older Adult - A151611
Toxicities and related outcomes of elderly patients (≥65 years) with hematologic malignancies in the contemporary era (Alliance A151611) Tallarico, Michael , Foster, Jared , Seisler, Drew ... - ASH - Blood - 2016 Abstract - Primary Endpoint - Comprehensive Analysis - Older Adult - CALGB-10101 , A151611 , CALGB-10404 , CALGB-10501 , CALGB-19805 , CALGB-19901 , CALGB-50002 , CALGB-50103 , CALGB-50201 , CALGB-50401 , CALGB-50402 , CALGB-50501 , CALGB-50602 , CALGB-50701 , CALGB-50803
QOL and Survival Comparisons by Race in Oncology Clinical Trials Tan, AD , Novotny, PJ , Kaur, JS , Buckner, JC , Mowat, RB , Paskett, E ... - - J Cancer Clin Oncol - 2016 Manuscript - Secondary Endpoint - Comprehensive Analysis - Disparities - N0621 , N0691
A pilot, randomized trial of daily lisinopril vs placebo to prevent radiation-induced pulmonary distress (Alliance MC1221) Terence T. Sio , Pamela J. Atherton , W. Ken Zhen , Yolanda I. Garces ... - IASLC (WCLC) - - 2017 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01880528
A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance) Thanarajasingam, Gita , Atherton, Pamela J. , Novotny, Paul J. ... - - Lancet Oncol. - 2016 Manuscript - Primary Endpoint - Comprehensive Analysis - Health Outcome - N9741 , NCCTG-97-92-54
Beyond maximum grade: A novel, longitudinal toxicity over time (ToxT) adverse event analysis of lenalidomide in follicular lymphoma in Alliance A151617 Thanarajasingam, Gita , Dueck, Amylou , Novotny, Paul J. ... - ICML - Hematol Oncol - 2017 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-50401 , A151617
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an Alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. Ustun, Celalettin , Le-Rademacher, Jennifer , Wang, Hai-Lin ... - - Leukemia - 2019 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - A151509 , CALGB-10502 , CALGB-100103 , CALGB-10801 , CALGB-11001 , CALGB-11002 , E3999 , S0432 , S0703
5-year Follow-up of a Randomized Controlled Trial of Immediate versus Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letrozole after Tamoxifen: N03CC (Alliance) Wagner-Johnston, Nina D. , Sloan, Jeff A. , Liu, Heshan ... - - Cancer - 2015 Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Symptom Inter - N03CC
Impact of Race, Ethnicity and BMI on Achievement of Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer: A Pooled Analysis of Four Prospective Alliance Clinical Trials (A151426) Warner, Erica T. , Ballman, Karla V. , Strand, Carrie , Boughey, Judy ... - - Breast Cancer Res. Treat. - 2016 Manuscript - Primary Endpoint - Comprehensive Analysis - Disparities - A151426 , ACOSOG-Z1041 , ACOSOG-Z1071 , CALGB-40601 , CALGB-40603
Age, Race, BMI and Pathologic Complete Response Following Neoadjuvant Chemotherapy: An Analysis of Four Alliance Clinical Trials Warner, Erica T. , Ballman, Karla V. , Strand, Carrie ... - ASCO Breast - J. Clin. Oncol. - 2015 Abstract - Primary Endpoint - Comprehensive Analysis - Disparities - A151426 , ACOSOG-Z1031 , ACOSOG-Z1041 , CALGB-40601 , CALGB-40603
Economic analysis of the Clinical Outcomes of Surgical Therapy (COST) trial comparing laparoscopically-assisted colectomy (LAC) with open colectomy (OC) for colon cancer. Weeks, J. , Nelson, H. , Romanus, D. , Long, K. ... - - J. Clin. Oncol. - 2008 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - INT-0146 , NCCTG-93-46-55 , CALGB-9396
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA Wolf, S. L. , Barton, D. L. , Qin, R. , Wos, E. J. , Sloan, J. A. ... - - Support Care Cancer - 2012 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - N06CA
Relationship of sensory symptoms and motor function in patients with chemotherapy-induced peripheral neuropathy (CIPN) utilizing the EORTC QLQ CIPN20: NCCTG study N06CA Wolf, S. L. , Qin, R. , Barton, D. L. , Sloan, J. A. , Liu, H. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - N06CA
Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5 Wolf, S. L. , Qin, R. , Menon, S. P. , Rowland, K. M., Jr ... - - J. Clin. Oncol. - 2010 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - N05C5
Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5 Wolf, Sherry L. , Qin, Rui , Menon, Smitha P. , Rowland, Kendrith M. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N05C5
Comparison of chemotherapy toxicity over time according to age and performance status in patients with advanced non-small cell lung cancer: a toxicity over time analysis of CALGB 9730 (Alliance A151729) Wong, Melisa L. , Gao, Junheng , Thanarajasingam, Gita ... - SIOG (ISOG) - J Geriatric Oncol - 2018 Abstract - Primary Endpoint - Primary Analysis - Older Adult - CALGB-9730
A randomized phase II trial of vitamin D vs placebo in premenopausal women: CALGB 70806 Wood, M. E. , Kinglsey, F. , Ambaye, A. B. , Yee, L. , Jung, S. J. ... - AACR - Cancer Res. - 2011 Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Prevention - CALGB-70806
Influence of vitamin D (Vit D) on mammographic density (MD) and insulin like growth factor 1 (IGF1): results of CALGB (Alliance) 70806 Wood, Marie , Seisler, Drew K. , Hsieh, Meng-Kang , Kontos, Despina ... - ASCO - J. Clin. Oncol. - 2018 Abstract - Primary Endpoint - Primary Analysis - Prevention - CALGB-70806
Objective Measures of Performance Status in Cancer: A pilot Alliance study Wood, WA , Tan, X , Grover, NS , Stover, A , Kannappan, A ... - ASCO QCS - J Clin Oncol - 2018 Abstract - No-Endpoint Endpoint - Primary Analysis - Disparities - Pilot
Venlafaxine to prevent oxaliplatin-induced neuropathy?: A pilot randomized placebo-controlled trial. Zimmerman, Collin Thomas , Atherton, Pamela J. , Pachman, Deirdre R. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01611155
Venlafaxine to Prevent Oxaliplatin-Induced Neuropathy? A Pilot Randomized Placebo Controlled Trial Zimmerman, Collin , Atherton, Pam , Pachman, Deirdre , Seisler, Drew ... - MASCC / ISOO - Support Care Cancer - 2015 Abstract - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01611155
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy Zimmerman, Collin , Atherton, Pamela J. , Pachman, Deirdre ... - - Support Care Cancer - 2016 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - NCT01611155
